Therapeutic Targeting of the Respiratory Microbiome
Am J Respir Crit Care Med
2022 Sep 1;206(5):535-544.
Sanjay H Chotirmall
James D Chalmers
Michael J Cox
Philip M Hansbro
Yvonne J Huang
Philip L Molyneaux
David N O'Dwyer
Alexa A Pragman
Geraint B Rogers
Leopoldo N Segal
Robert P Dickson
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore.
Center for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom.
Department of Paediatric Immunology and Infectious Diseases, University Medical Center Utrecht, Utrecht, the Netherlands.
Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, New South Wales, Australia.
Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, New South Wales, Australia.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, and.
Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan.
National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Medicine, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota.
Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Microbiome and Host Health, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
Infection and Immunity, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
Division of Pulmonary, Critical Care, and Sleep Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, New York; and.
Weil Institute for Critical Care Research and Innovation, Ann Arbor, Michigan.
No abstract available
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, Non-U.S. Gov't
Grants and funding
SCAF/16/03/CSO_/Chief Scientist Office/United Kingdom
R01 HL144599/HL/NHLBI NIH HHS/United States
R56HL155055/NH/NIH HHS/United States
SCAF/17/03/CSO_/Chief Scientist Office/United Kingdom
UL1TR002494/NH/NIH HHS/United States
I01 CX002130/CX/CSRD VA/United States
R37CA244775/NH/NIH HHS/United States
T32HL007749/NH/NIH HHS/United States
IK2 CX001095/CX/CSRD VA/United States
K24 HL159247/HL/NHLBI NIH HHS/United States
R00 HL139996/HL/NHLBI NIH HHS/United States
R01AI129958/NH/NIH HHS/United States
R00HL139996/NH/NIH HHS/United States
R01HL144599/NH/NIH HHS/United States
R01 AI129958/AI/NIAID NIH HHS/United States
R56 HL155055/HL/NHLBI NIH HHS/United States